Tableaux’s GE HealthCare GEHC Stock Holding History

Tableaux’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,011	Closed	-$301K	–	102
2025 Q3	$301K	Buy	+4,011	New	+$299K	0.12%	96

Other funds holding GEHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Tableaux's GEHC Position: Q4 2025 in Review

Tableaux sold out of GE HealthCare (GEHC) in Q4 2025, closing a stake of 4,011 shares — an estimated $301K sold.

Tableaux first reported a position in GEHC in Q3 2025 and held it in 1 quarter. The position peaked at $301K in Q3 2025. 1,335 funds tracked by Wall St. Rank hold GEHC as of Q4 2025.

Tableaux reported no remaining GE HealthCare position as of Q4 2025 after selling out during the quarter.
Tableaux sold 4,011 GE HealthCare shares in Q4 2025, an estimated $301K.
Tableaux first reported a position in GE HealthCare in Q3 2025 and held it in 1 quarter.
Tableaux's GE HealthCare position peaked at $301K in Q3 2025.
1,335 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2025.

Based on Tableaux's 13F filing for Q4 2025, filed 13 Feb 2026.